|
Source: https://www.bioopticsworld.com
08/27/2013
Scientists at McGill University (Montreal, QC, Canada) have crystallized a short RNA sequence, poly (rA)11, and used data collected at the Canadian Light Source (CLS; Saskatoon, SK, Canada) and the medical diagnostics (Ithaca, NY) to confirm the hypothesis of a poly (rA) double helix. Their discovery, building on 50 years' worth of work by various scientists, will have interesting applications for research in biological nanomaterials as well as in fabricating bionanomachines (devices derived from living organisms that can perform Related: AFM collaboration produces first in-situ view of DNA's double helix).
https://onlinelibrary.wiley.com/doi/10.1002/anie.201303461/abstract
“Bionanomachines are advantageous because of their extremely small
size, low production cost, and the ease of modification,” explains Kalle
Gehring, a biochemistry professor at McGill University who led the
work. “Many bionanomachines already affect our everyday lives as
enzymes, sensors, biomaterials, and medical therapeutics.”
Gehring adds that proof of the RNA double helix may have diverse
downstream benefits for the medical treatments and cures for diseases
like AIDS, or even to help regenerate biological tissues. His team
initially was looking for information about how cells turn mRNA into
protein when they made their discovery.
For the experiments, Gehring and a team of researchers used data
obtained at the CLS Canadian Macromolecular Crystallography Facility
(CMCF) to successfully solve the structure of poly (rA)11 RNA. CMCF
Beamline Scientist Michel Fodje said the experiments were successful in
identifying the structure of the RNA and may have consequences for how
genetic information is stored in cells.
The Wall